PATENT CLAIM ANALYSIS

Application Number: 15910987
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["435", "007100"]

Abstract:
The invention relates to purinergic (P2X) receptors, more specifically to P2X7 receptors, the generation of antibodies and the use of antibodies and immunogens that are capable of selectively binding to a non ATP-binding P2X7 receptor but not to an ATP-binding P2X7 receptor, for the detection and treatment of disease conditions, especially cancer.

Claim (Index 21):
The method according to claim  7 , wherein the cancer is selected from prostate, breast, skin, lung, cervix, uterus, ovarian, stomach, oesophagus, bladder, and colon cancers.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 90.0
- Lexical Diversity: 1.475
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13841692', '14877715', '12677799', '12445273', '12677795']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.597559048287987
- 35 USC 102 Novelty (BERT): 0.5409033918836847
- Combined Prediction Score: 0.5918934826475568
- Mean Citation Score: 340.181844
- Max Citation Score: 375.5822
- Similarity Product: 355.67617433757783

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test